☆ 4.6 Letter

Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer's disease

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Volume 90, Issue 6, Pages 728-730

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/jnnp-2018-318445

Keywords

-

Categories

Clinical Neurology Psychiatry Surgery

Funding

Norwegian Health Association
National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Clinical Neurology

Idiopathic primary intraventricular hemorrhage and cerebral small vessel disease

Alvin S. Das, Robert W. Regenhardt, Elif Gokcal, Mitchell J. Horn, Nader Daoud, Kristin M. Schwab, Natalia S. Rost, Anand Viswanathan, W. Taylor Kimberly, Joshua N. Goldstein, Alessandro Biffi, Lee H. Schwamm, Jonathan Rosand, Steven M. Greenberg, M. Edip Gurol

Summary: The study found that approximately one-third of IP-IVH patients had cerebral amyloid angiopathy, and 23% had hypertensive small vessel disease. This suggests that both types of small vessel diseases may be associated with IP-IVH.

INTERNATIONAL JOURNAL OF STROKE (2022)

Add to Collection

Article Clinical Neurology

Neuropathology of Vascular Brain Health Insights From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease

Susanne J. van Veluw, Konstantinos Arfanakis, Julie A. Schneider

Summary: Sporadic cerebral small vessel disease is a major cause of cognitive impairment and dementia in aging brains, characterized by brain small vessel abnormalities and frequently coexisting with Alzheimer disease changes. Ex vivo MRI is a powerful tool to bridge the gap in understanding the underlying neuropathology of MRI-detectable SVD abnormalities.

STROKE (2022)

Add to Collection

Article Neurosciences

Neuroimaging biomarkers of small vessel disease in cerebral amyloid angiopathy-related intracerebral hemorrhage

Mengke Zhang, Ruiwen Che, Wenbo Zhao, Hailiang Sun, Changhong Ren, Jin Ma, Wenbo Hu, Milan Jia, Chuanjie Wu, Xin Liu, Xunming Ji

Summary: This study aimed to explore the relationship between computed tomography (CT)-based cerebral small vessel disease (SVD) markers and the clinical outcomes in patients with cerebral amyloid angiopathy (CAA)-related intracerebral hemorrhage (ICH). The results showed that the SVD markers based on CT could predict the short-term outcome more effectively in patients with CAA-ICH. Further studies are needed to validate these findings and identify modifiable factors for preventing CAA-ICH development.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Add to Collection

Article Neuroimaging

Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer's disease

Nandakumar Nagaraja, Steven Dekosky, Ranjan Duara, Lan Kong, Wei-en Wang, David Vaillancourt, Mehmet Albayram

Summary: Among Alzheimer's disease patients, occipital predominant white matter hyperintensities (WMH) are more likely to be found in severe cerebral amyloid angiopathy (CAA) patients compared to those without. However, high grade enlarged perivascular spaces (ePVS) in the centrum semiovale are common in all AD patients regardless of CAA severity. On imaging, WMH and ePVS are not correlated with the number of ApoE ε4 alleles but correlate with the presence of infarcts, lacunes, and microinfarcts on neuropathology.

NEUROIMAGE-CLINICAL (2023)

Add to Collection

Article Geriatrics & Gerontology

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment

Mana Shams, Sara Shams, Juha Martola, Lena Cavallin, Tobias Granberg, Magnus Kaijser, Max Wintermark, Eric Westman, Peter Aspelin, Maria Kristoffersen Wiberg, Lars-Olof Wahlund

Summary: The study found that APOE epsilon 4 is associated with MRI markers of SVD related to amyloid pathology, specifically CMBs and A beta 42 plaque formation in the brain, as reflected by decreased CSF A beta 42 levels. On the other hand, APOE epsilon 3 and epsilon 2 are associated with markers of hypertensive arteriopathy, such as the association with CMBs in deep and infratentorial brain regions.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation

Yasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Toshiya Nomura, Yukio Ando, Mitsuharu Ueda

Summary: In this study, the researchers found that α-enolase (ENO1) can interact with amyloid beta (Aβ) and inhibit its fibril formation. They also demonstrated that ENO1 can disrupt Aβ fibrils and weaken their cytotoxic effects by degrading Aβ peptides. Additionally, infusion of ENO1 into mouse brains reduced cerebrovascular Aβ deposits and improved cognitive impairment. These findings suggest that ENO1 may be a therapeutic target in cerebral amyloid angiopathy (CAA).

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Neurosciences

Spontaneous intracerebral haemorrhage associated with early-onset cerebral amyloid angiopathy and Alzheimer's disease neuropathological changes five decades after cadaveric dura mater graft

Riccardo Milani, Lucio Aniello Mazzeo, Daniela Vismara, Ilaria Salemi, Emanuele Dainese, Emanuela Maderna, Elisa Pellencin, Marcella Catania, Nicole Campanella, Giuseppe Di Fede, Giorgio Giaccone, Andrea Salmaggi

Summary: Cerebral amyloid angiopathy (CAA) is a small vessel disease that leads to spontaneous intracerebral hemorrhage (ICH) in the elderly and is strongly associated with Alzheimer's disease (AD). Recently, iatrogenic early-onset CAA has been identified in patients who had a history of traumatic brain injury or other cerebral and extra-cerebral lesions that required neurosurgery or other medical procedures. The transmission of A beta seeds from neurosurgical instruments or exposure to cadaveric dura mater is suspected to be involved.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

In Vivo Dynamic Movement of Polymerized Amyloid β in the Perivascular Space of the Cerebral Cortex in Mice

Itsuki Hasegawa, Yoko Hirayoshi, Shinobu Minatani, Toshikazu Mino, Akitoshi Takeda, Yoshiaki Itoh

Summary: This study explored the in vivo dynamics of amyloid beta (Aβ) in the perivascular space of the cerebral cortex in mice. The researchers observed the accumulation of Aβ in the localized perivascular space and found that transportation along the vessels was slow and associated with changes in shape. The study also confirmed the transportation of Aβ between the cortical surface and the deeper parenchyma through the perivascular space.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Clinical Neurology

Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy

Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleo, Jurgen A. H. R. Claassen, Marcel M. Verbeek

Summary: Our study found that CSF NLK levels are elevated in aMCI and AD patients compared to controls, but did not increase in CAA patients. Furthermore, we observed a correlation of CSF NLK with CSF YKL-40 in aMCI/AD patients.

ALZHEIMERS RESEARCH & THERAPY (2021)

Add to Collection

Article Neurosciences

Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease

Nandakumar Nagaraja, Wei-en Wang, Ranjan Duara, Steven T. DeKosky, David Vaillancourt

Summary: This study aimed to evaluate whether cerebral amyloid angiopathy (CAA) pathology mediates hippocampal atrophy in Alzheimer's disease (AD) patients. The results showed that severe CAA was associated with smaller left hippocampal volume on T1-MRI in patients with neuropathologically confirmed AD, and this relationship was dependent on APOE ε4 genotype.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Add to Collection

Review Clinical Neurology

Clinical considerations in early-onset cerebral amyloid angiopathy

Gargi Banerjee, John Collinge, Nick C. Fox, Tammaryn Lashley, Simon Mead, Jonathan M. Schott, David J. Werring, Natalie S. Ryan

Summary: Cerebral amyloid angiopathy (CAA) is a significant cerebral small vessel disease that is associated with brain haemorrhage and cognitive change. While the common form affects individuals in mid- to later life, rare early-onset forms are increasingly recognized and may be caused by genetic or iatrogenic factors. This review provides an overview of the causes of early-onset CAA and proposes a structured approach for investigation and management, aiming to raise awareness among healthcare professionals.

BRAIN (2023)

Add to Collection

Article Neurosciences

Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes

Jonathan Graff-Radford, Timothy G. Lesnick, Michelle M. Mielke, Eleni Constantopoulos, Alejandro A. Rabinstein, Scott A. Przybelski, Prashanthi Vemuri, Hugo Botha, David T. Jones, Vijay K. Ramanan, Ronald C. Petersen, David S. Knopman, Bradley F. Boeve, Melissa E. Murray, Dennis W. Dickson, Clifford R. Jack, Kejal Kantarci, R. Ross Reichard

Summary: This study found a correlation between cerebral microbleeds (CMBs) and cerebral amyloid angiopathy (CAA) using MRI and autopsy data. The capillary and leptomeningeal/cortical CAA scores were closely associated with lobar CMBs, with the capillary component being a stronger predictor of lobar CMBs.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Add to Collection

Article Clinical Neurology

Association between cortical microinfarcts and total small vessel disease burden in cerebral amyloid angiopathy on 3-Tesla magnetic resonance imaging

Yuichiro Ii, Hidehiro Ishikawa, Akihiro Shindo, Hirofumi Matsuyama, Keita Matsuura, Kana Matsuda, Kimiko Yoshimaru, Masayuki Satoh, Ryota Kogue, Maki Umino, Masayuki Maeda, Hidekazu Tomimoto

Summary: The study found that the presence of CMIs with a high CAA-SVD score could be an indicator of more severe amyloid-associated vasculopathic changes in patients with probable CAA. CMIs were more frequently detected in the parietal and occipital lobes.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Add to Collection

Review Cell Biology

Cerebral amyloid angiopathy-related cardiac injury: Focus on cardiac cell death

Xiaofang Xu, Huikang Xu, Zhaocai Zhang

Summary: Cerebral amyloid angiopathy (CAA) is a disease characterized by the deposition of amyloid beta (A beta) and other amyloid proteins in the brain's blood vessels, leading to cerebrovascular and brain damage. CAA is often associated with cardiac injury, involving A beta, tau, and transthyroxine amyloid (ATTR). A beta acts as the main damaging factor, causing coronary artery atherosclerosis, aortic valve calcification, and cardiomyocyte degeneration. The progression of CAA can further impact the heart through amyloidosis, inflammation, and cerebral hemorrhage. The interaction between CAA and cardiac injury creates a vicious cycle that accelerates the progression of both conditions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Data Mining of Molecular Simulations Suggest Key Amino Acid Residues for Aggregation, Signaling and Drug Action

Vaibhav Gurunathan, John Hamre, Dmitri K. Klimov, Mohsin Saleet Jafri

Summary: Alzheimer's disease, the most common form of dementia, currently has no cure. This study utilized machine learning techniques and molecular dynamics simulation data to explore the relationship between A beta torsion angles and disease measures. The research has the potential to help determine which specific residues of A beta should be targeted for drug development.

BIOMOLECULES (2021)

Add to Collection

Article Clinical Neurology

Regression-based norms for the FAS phonemic fluency test for ages 40-84 based on a Norwegian sample

Ingrid Myrvoll Lorentzen, Jacob Espenes, Erik Hessen, Knut Waterloo, Geir Brathen, Santiago Timon, Dag Aarsland, Tormod Fladby, Bjorn-Eivind Kirsebom

Summary: The study developed regression-based norms for the FAS phonemic fluency test and found that years of education was the only significant predictor of test performance. The proposed norms provided a more accurate adjustment for demographics in the Norwegian population compared to American norms.

APPLIED NEUROPSYCHOLOGY-ADULT (2023)

Add to Collection

Article Public, Environmental & Occupational Health

What does feeling younger or older than one's chronological age mean to men and women? Qualitative and quantitative findings from the PROTECT study

Serena Sabatini, Obioha C. Ukoumunne, Clive Ballard, Rachel Collins, Sarang Kim, Anne Corbett, Dag Aarsland, Adam Hampshire, Helen Brooker, Linda Clare

Summary: This study explored the factors associated with subjective age, finding that it may result from the interaction between factors that increase or decrease age-related thoughts and mental processes. The results show that individuals reporting an older subjective age are more likely to experience significant negative changes and engage in negative age-related thoughts. Women experience a more negative subjective age and more age-related events than men.

PSYCHOLOGY & HEALTH (2023)

Add to Collection

Article Clinical Neurology

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Willemijn J. Jansen, Olin Janssen, Betty M. Tijms, Stephanie J. B. Vos, Rik Ossenkoppele, Pieter Jelle Visser

Summary: This study aims to estimate the prevalence of amyloid abnormality in individuals with different cognitive statuses and examine the factors that may affect these estimates. The results show that CSF-based estimates using adjusted data-driven cutoffs were higher than PET-based estimates in individuals without dementia, suggesting that preclinical and prodromal AD may be more prevalent than previously estimated. This finding has important implications for clinical trial recruitment strategies and healthcare planning policies.

JAMA NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

European consensus for the diagnosis of MCI and mild dementia: Preparatory phase

Cristina Festari, Federico Massa, Matteo Cotta Ramusino, Federica Gandolfo, Valentina Nicolosi, Stefania Orini, Dag Aarsland, Federica Agosta, Claudio Babiloni, Merce Boada, Barbara Borroni, Stefano Cappa, Bruno Dubois, Kristian S. Frederiksen, Lutz Froelich, Valentina Garibotto, Jean Georges, Alexander Haliassos, Oskar Hansson, Frank Jessen, Anita Kamondi, Roy P. C. Kessels, Silvia Morbelli, John T. O'Brien, Markus Otto, Armand Perret-Liaudet, Francesca B. Pizzini, Craig W. Ritchie, Philip Scheltens, Mathieu Vandenbulcke, Ritva Vanninen, Frans Verhey, Meike W. Vernooij, Tarek Yousry, Wiesje M. Van der Flier, Flavio Nobili, Giovanni B. Frisoni

Summary: This study developed a pan-European workflow for the etiological diagnosis of neurocognitive disorders in middle-old age based on biomarkers. The workflow was developed through a Delphi consensus method and a systematic literature review, aiming to provide guidance for the rational use of biomarkers in clinical practice.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Article Geriatrics & Gerontology

A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia

Dag Aarsland, Khadija Khalifa, Anne K. Bergland, Hogne Soennesyn, Ketil Oppedal, Lise B. A. Holteng, Ragnhild Oesterhus, Arne Nakling, Jonas A. Jarholm, Chiara de Lucia, Tormod Fladby, Helen Brooker, Ingvild Dalen, Clive Ballard

Summary: This study aimed to investigate the safety and effectiveness of anthocyanins, a nutritional compound, in maintaining cognitive functioning in older people. The 24-week trial on 206 participants with mild cognitive impairment or cardiometabolic disorders showed that anthocyanin supplementation was safe and well-tolerated. Although there was no significant group difference in episodic memory at the end of the study, there were significant differences in slopes during weeks 8-24, with improvement in the anthocyanin group and deterioration in the placebo group.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Add to Collection

Article Clinical Neurology

Structural synaptic signatures of Alzheimer's disease and dementia with Lewy bodies in the male brain

Oleg O. Glebov, David Williamson, Dylan M. Owen, Tibor Hortobagyi, Claire Troakes, Dag Aarsland

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Add to Collection

Article Psychology, Clinical

Regression-Based Cognitive Change Norms Applied in Biochemically Defined Predementia Alzheimer's Disease

Ingvild Vollo Eliassen, Bjorn-Eivind Kirsebom, Tormod Fladby, Knut Waterloo, Sigrid Botne Sando, Mathilde Suhr Hemminghyth, Dag Aarsland, Santiago Timon-Reina, Anders Wallin, Fredrik Ohman, Marie Eckerstrom, Erik Hessen

Summary: This study aimed to develop 2-year cognitive change norms for adults aged 41-84 and evaluated these norms in groups with AD biomarkers. The results showed that the group with cognitive complaints exhibited a trend of cognitive decline, with the A+T/N+ subgroup showing the most significant decline.

NEUROPSYCHOLOGY (2023)

Add to Collection

Article Behavioral Sciences

The cognitive profile of middle-aged and older adults with high vs. low autistic traits

Gavin R. Stewart, Anne Corbett, Clive Ballard, Byron Creese, Dag Aarsland, Adam Hampshire, Helen Brooker, Rebecca A. Charlton, Francesca Happe

Summary: Cognitive differences in memory, information processing speed, and executive functions are common in autistic and high autistic trait populations. Older adults with high autistic traits experience more difficulties in memory, IPS, and EF tasks compared to those with low autistic traits. Further research is needed to examine age-related changes in cognitive profiles of older adults with autism traits.

AUTISM RESEARCH (2023)

Add to Collection

Review Geriatrics & Gerontology

Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update

Marianna Rogowska, Mary Thornton, Byron Creese, Latha Velayudhan, Dag Aarsland, Clive Ballard, Konstantinos Tsamakis, Robert Stewart, Christoph Mueller

Summary: Neuropsychiatric symptoms are common in patients with dementia and can lead to distress, rapid disease progression, and higher mortality. Non-pharmacological management should be the first-line treatment, but if medications are necessary, second-generation antipsychotics are commonly used. However, antipsychotic use in dementia is associated with adverse outcomes such as increased mortality, pneumonia, and cerebrovascular events. The risks are influenced by various factors, making individualized treatment decisions challenging. Close monitoring and early withdrawal of pharmacotherapy when possible can help mitigate these risks.

DRUGS & AGING (2023)

Add to Collection

Article Medicine, General & Internal

Antidepressant drug prescription and incidence of COVID-19 in mental health outpatients: a retrospective cohort study

Oleg O. Glebov, Christoph Mueller, Robert Stewart, Dag Aarsland, Gayan Perera

Summary: A retrospective study found that antidepressant drugs, especially selective serotonin reuptake inhibitors, may reduce the risk of COVID-19 infection. However, the study was limited to a cohort of mental health outpatients and further prospective studies are needed to validate their potential preventative effect.

BMC MEDICINE (2023)

Add to Collection

Article Clinical Neurology

Between-person and within-person effects in the temporal relationship between depressive symptoms and cognitive function

Zsofia Csajbok, Dag Aarsland, Pavla Cermakova

Summary: This epidemiological study aimed to explore the temporal relationship between depressive symptoms and cognitive function. The results demonstrated a bidirectional association between the two, with cognitive function initially having a slightly stronger impact on depressive symptoms, and depressive symptoms having a stronger impact on cognitive function during follow-up. However, within-person effects showed a dominant influence of depressive symptoms on cognitive function.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Add to Collection

Article Behavioral Sciences

Grey matter volume loss in Parkinson's disease psychosis and its relationship with serotonergic gene expression: A meta-analysis

Sara Pisani, Brandon Gunasekera, Yining Lu, Miriam Vignando, Dominic Ffytche, Dag Aarsland, K. Ray Chaudhuri, Clive Ballard, Jee-Young Lee, Yu Kyeong Kim, Latha Velayudhan, Sagnik Bhattacharyya

Summary: This study conducted a meta-analysis of MRI studies to explore the neuroanatomical alterations underlying psychosis in Parkinson's Disease (PDP). The results revealed widespread grey matter volume loss in the parieto-temporo-occipital regions of PDP patients, which was associated with the expression of serotonergic receptor genes (5-HT1a and 5-HT2a), but not dopaminergic receptors.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2023)

Add to Collection

Article Clinical Neurology

Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia

Maria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, Ingvild Dalen, Caroline H. Williams-Gray, Marta Camacho, Lars Forsgren, David Backstrom, Rachael A. Lawson, Angus D. Macleod, Carl E. Counsell, Claire Paquet, Carlo DeLena, Fabrizia D'Antonio, Andrea Pilotto, Alessandro Padovani, Frederic Blanc, Cristian Falup-Pecurariu, Simon J. G. Lewis, Konrad Rejdak, Ewa Papuc, Jakub Hort, Zuzana Nedelska, John O'Brien, Laura Bonanni, Marta Marquie, Merce Boada, Vanesa Pytel, Carla Abdelnour, Daniel Alcolea, Katrin Beyer, Ole-Bjorn Tysnes, Dag Aarsland, Jodi Maple-Grodem

Summary: This study compares the rate of cognitive and motor decline in patients with DLB and PDD, finding that both disorders show similar rates of decline. This has implications for future clinical trial designs.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Identification and quantification of (poly)phenol and methylxanthine metabolites in human cerebrospinal fluid: evidence of their ability to cross the BBB

Melanie Le Sayec, Diogo Carregosa, Khadija Khalifa, Chiara de Lucia, Dag Aarsland, Claudia N. Santos, Ana Rodriguez-Mateos

Summary: This study investigated the presence of (poly)phenol and methylxanthine metabolites in plasma and cerebrospinal fluid from individuals at risk of dementia and predicted their transport mechanism across the blood-brain barrier using in silico modeling. The results suggest that (poly)phenols and methylxanthines can cross the blood-brain barrier via passive diffusion or transport carriers to exert neuroprotective effects.

FOOD & FUNCTION (2023)

Add to Collection

Article Psychology, Developmental

Associations of subjective cognitive and memory decline with depression, anxiety, and two-year change in objectively-assessed global cognition and memory

Serena Sabatini, Robert T. Woods, Obioha C. Ukoumunne, Clive Ballard, Rachel Collins, Linda Clare

Summary: The study found that more severe subjective cognitive decline (SCD) and subjective memory decline (SMD) may predict lower learning ability but do not significantly predict changes in objectively assessed global cognition, remote memory, and recent memory. Greater depression and anxiety are associated with more severe SCD and SMD.

AGING NEUROPSYCHOLOGY AND COGNITION (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.